Literature DB >> 26294712

Quantitative FDG-PET: a new biomarker in PMBCL.

Michel Meignan1.   

Abstract

In this issue of Blood, Ceriani et al introduce, in primary mediastinal B-cell lymphoma (PMBCL), a new prognostic factor measured on pretreatment 18F-fluorodeoxyglucose (18FDG)-positron emission tomography (PET)/computed tomography (CT): the total lesion glycolysis (TLG), which is an index of the glucose uptake by the total tumor burden. This paper is part of the International Extranodal Lymphoma Study Group (IELSG) 26 prospective study designed to evaluate the role of PET in the treatment of PMBCL.

Entities:  

Mesh：

Year:  2015        PMID： 26294712     DOI： 10.1182/blood-2015-07-653386

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  8 in total

1.  Interim FDG PET/CT in primary mediastinal diffuse large B-cell lymphoma: really almost useless procedure?

Authors:  Vít Procházka; Lenka Henzlová; Jaroslav Ptáček; Tomáš Papajík
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-02-03       Impact factor: 9.236

2.  Large-scale microarray profiling reveals four stages of immune escape in non-Hodgkin lymphomas.

Authors:  Marie Tosolini; Christelle Algans; Frédéric Pont; Bernard Ycart; Jean-Jacques Fournié
Journal:  Oncoimmunology       Date:  2016-05-19       Impact factor: 8.110

3.  Continuous infusion chemotherapy, radiotherapy, and FDG-PET are feasible during extracorporeal membrane oxygenation.

Authors:  Seth J Rotz; Francisco A Almeida; Shlomo Koyfman; Sudhir Krishnan; Guramrinder Singh Thind; William Phillips; James Yun; Anthony Zembillas; Mark Zahniser; Alejandro Bribriesco
Journal:  Pediatr Blood Cancer       Date:  2020-07-16       Impact factor: 3.167

4.  SAKK38/07 study: integration of baseline metabolic heterogeneity and metabolic tumor volume in DLBCL prognostic model.

Authors:  Luca Ceriani; Giuseppe Gritti; Luciano Cascione; Maria Cristina Pirosa; Angela Polino; Teresa Ruberto; Anastasios Stathis; Andrea Bruno; Alden A Moccia; Luca Giovanella; Stefanie Hayoz; Sämi Schär; Stefan Dirnhofer; Alessandro Rambaldi; Giovanni Martinelli; Christoph Mamot; Emanuele Zucca
Journal:  Blood Adv       Date:  2020-03-24

5.  Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.

Authors:  Hongxi Wang; Guohua Shen; Chong Jiang; Li Li; Futao Cui; Rong Tian
Journal:  PLoS One       Date:  2018-03-20       Impact factor: 3.240

6.  Prognostic Value of Baseline and Interim Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT in Patients with Follicular Lymphoma.

Authors:  Jin-Hua Liang; Yun-Ping Zhang; Jun Xia; Chong-Yang Ding; Wei Wu; Li Wang; Lei Cao; Hua-Yuan Zhu; Lei Fan; Tian-Nv Li; Jian-Yong Li; Wei Xu
Journal:  Cancer Res Treat       Date:  2019-03-12       Impact factor: 4.679

7.  Prognostic significance of clinical characteristics and 18Fluorodeoxyglucose-positron emission tomography/computed tomography quantitative parameters in patients with primary mediastinal B-cell lymphoma.

Authors:  Yizhen Liu; Jinjin Jiang; Lianfang Liu; Zezhou Wang; Baohua Yu; Zuguang Xia; Qunling Zhang; Dongmei Ji; Xiaojian Liu; Fangfang Lv; Xiaonan Hong; Shaoli Song; Junning Cao
Journal:  J Int Med Res       Date:  2022-01       Impact factor: 1.671

Review 8.  Primary mediastinal large B cell lymphoma.

Authors:  Yating Yu; Xifeng Dong; Meifeng Tu; Huaquan Wang
Journal:  Thorac Cancer       Date:  2021-09-29       Impact factor: 3.500
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.